Perceived Stress and Vascular Disease: Where Are We Now?

被引:18
|
作者
Katsarou, Alexia L. [1 ]
Triposkiadis, Filippos [1 ]
Panagiotakos, Demosthenes [2 ]
机构
[1] Univ Thessaly, Dept Cardiol, Sch Med, Larisa 41222, Greece
[2] Univ Athens, Grp Biostat Epidemiol & Res Methods, Dept Nutr & Dietet, Athens, Greece
关键词
acute coronary symptoms; coronary heart disease; cardiovascular disease; perceived stress; stress perception; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PSYCHOLOGICAL STRESS; METABOLIC SYNDROME; RISK-FACTORS; PSYCHOSOCIAL FACTORS; 52; COUNTRIES; MORTALITY; MEN;
D O I
10.1177/0003319712458963
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Apart from traditional risk factors, psychosocial characteristics are increasingly considered as potential predictors of cardiovascular disease (CVD). The concept of stress is relevant when discussing the relationship between psychosocial factors and CVD. Among stress types and definitions (ie, marital stress, work stress), perceived stress presents a global and comprehensive stress construct and is based on the concept that individuals actively interact with their environment, appraising potentially threatening or challenging events in the light of available coping resources. However, the role of perceived stress in CVD incidence has not yet been completely elucidated. Thus, we evaluate perceived stress as a CVD risk factor by reviewing the literature. We also discuss the relationship between negative affect and CVD development.
引用
收藏
页码:529 / 534
页数:6
相关论文
共 50 条
  • [1] Sleep apnoea, hypertension and vascular disease: where are we now?
    Buyse, B.
    Hedner, J.
    [J]. EUROPEAN RESPIRATORY REVIEW, 2007, 16 (106): : 169 - 182
  • [2] Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go?
    Screm, Gianluca
    Mondini, Lucrezia
    Salton, Francesco
    Confalonieri, Paola
    Trotta, Liliana
    Barbieri, Mariangela
    Romallo, Antonio
    Galantino, Alessandra
    Hughes, Michael
    Lerda, Selene
    Confalonieri, Marco
    Ruaro, Barbara
    [J]. DIAGNOSTICS, 2024, 14 (09)
  • [3] Fabry disease: where are we now?
    K. Turkmen
    I. Baloglu
    [J]. International Urology and Nephrology, 2020, 52 : 2113 - 2122
  • [4] Fabry disease: where are we now?
    Turkmen, K.
    Baloglu, I.
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (11) : 2113 - 2122
  • [5] Probiotics and Liver Disease Where Are We Now and Where Are We Going?
    Elzouki, Abdel-Naser
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 : S188 - S190
  • [6] Oxidative stress and neurodegeneration: where are we now?
    Halliwell, Barry
    [J]. JOURNAL OF NEUROCHEMISTRY, 2006, 97 (06) : 1634 - 1658
  • [7] Exercise stress echocardiography: Where are we now?
    Cotrim, Carlos Alberto
    Cafe, Hugo
    Joao, Isabel
    Cotrim, Nuno
    Guardado, Jorge
    Cordeiro, Pedro
    Cotrim, Hortense
    Baquero, Luis
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (02): : 64 - 82
  • [9] Measurements of Oxidative Stress - Where are we Now?
    Breusing, N.
    Grune, T.
    [J]. AKTUELLE ERNAHRUNGSMEDIZIN, 2008, 33 (03): : 106 - 115
  • [10] Vascular factors in cognitive impairment - Where are we now?
    Hachinski, V
    Munoz, D
    [J]. VASCULAR FACTORS IN ALZHEIMER'S DISEASE, 2000, 903 : 1 - 5